OBJECTIVE: To evaluate the protective effects of an haemostatic ointment, at rhinosinusal mucosa level, on the development of bleeding in patients affected by epistaxis or with a positive clinical history for epistaxis in previous 7 days. PATIENTS AND METHODS: 100 patients affected by epistaxis or with a positive clinical history for epistaxis in previous 7 days. Patients underwent 15 days of treatment with an haemostatic ointment 2 times/day. RESULTS: The haemostatic ointment significantly reduced the percentage of patients affected by epistaxis and the number and severity of bleeding episodes (p < 0.001). 51% of patients experienced nasal obstruction during treatment, which persisted at the end of therapy only in 11% of them (p < 0.001). Nasal burning, nasal itching and rinorrhea involved less than 40% of patients in the first days of treatment and no more than 10% at the end of therapy (p < 0.001). CONCLUSIONS: The use of the haemostatic ointment in the treatment and in the prevention of not severe epistaxis acquire, in our opinion, a strong rationale.

Passali, D., Gruppo di Studio, E. (2005). Haemostatic ointment efficacy in the treatment and prevention of epistaxis: a multi-centric study in 100 patients [Efficacia di un unguento emostatico nel trattamento e nella prevenzione dell'epistassi: Uno studio multicentrico su 100 pazienti]. LA CLINICA TERAPEUTICA, 156(4), 139-143.

Haemostatic ointment efficacy in the treatment and prevention of epistaxis: a multi-centric study in 100 patients [Efficacia di un unguento emostatico nel trattamento e nella prevenzione dell'epistassi: Uno studio multicentrico su 100 pazienti]

Passali D.;
2005-01-01

Abstract

OBJECTIVE: To evaluate the protective effects of an haemostatic ointment, at rhinosinusal mucosa level, on the development of bleeding in patients affected by epistaxis or with a positive clinical history for epistaxis in previous 7 days. PATIENTS AND METHODS: 100 patients affected by epistaxis or with a positive clinical history for epistaxis in previous 7 days. Patients underwent 15 days of treatment with an haemostatic ointment 2 times/day. RESULTS: The haemostatic ointment significantly reduced the percentage of patients affected by epistaxis and the number and severity of bleeding episodes (p < 0.001). 51% of patients experienced nasal obstruction during treatment, which persisted at the end of therapy only in 11% of them (p < 0.001). Nasal burning, nasal itching and rinorrhea involved less than 40% of patients in the first days of treatment and no more than 10% at the end of therapy (p < 0.001). CONCLUSIONS: The use of the haemostatic ointment in the treatment and in the prevention of not severe epistaxis acquire, in our opinion, a strong rationale.
2005
Passali, D., Gruppo di Studio, E. (2005). Haemostatic ointment efficacy in the treatment and prevention of epistaxis: a multi-centric study in 100 patients [Efficacia di un unguento emostatico nel trattamento e nella prevenzione dell'epistassi: Uno studio multicentrico su 100 pazienti]. LA CLINICA TERAPEUTICA, 156(4), 139-143.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/37653
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo